MTI Ltd. (TYO:9438)
Japan · Delayed Price · Currency is JPY 846.00
-7.00 (-0.82%)
Sep 5, 2025, 3:30 PM JST
MTI Ltd. Revenue
MTI Ltd. had revenue of 7.42B JPY in the quarter ending June 30, 2025, with 5.73% growth. This brings the company's revenue in the last twelve months to 29.44B, up 8.25% year-over-year. In the fiscal year ending September 30, 2024, MTI Ltd. had annual revenue of 27.67B with 3.25% growth.
Revenue (ttm)
29.44B
Revenue Growth
+8.25%
P/S Ratio
1.59
Revenue / Employee
24.86M
Employees
1,184
Market Cap
46.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 27.67B | 871.00M | 3.25% |
| Sep 30, 2023 | 26.80B | 319.00M | 1.20% |
| Sep 30, 2022 | 26.48B | 736.00M | 2.86% |
| Sep 30, 2021 | 25.74B | -339.00M | -1.30% |
| Sep 30, 2020 | 26.08B | -1.03B | -3.80% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.21B |
| Takeda Pharmaceutical Company | 4,480.25B |
| HOYA Corporation | 876.09B |
| Daiichi Sankyo Company | 1,924.68B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |